Reference Source

Optimum Compounding Pharmacy

For Optimum Compounding Pharmacy, import alert is 66-57; import alert name is "Detention Without Physical Examination of Foreign Manufactured Unapproved Prescription Drugs Distributed to Individuals in the U.S."; country is CANADA; address is 10171 Yonge St , Richmond Hill, Ontario CANADA; date published is 09/10/2009, verified against its source on 2026-08-06.

Firm
Optimum Compounding Pharmacy verified
Import alert
66-57 verified
Import alert name
"Detention Without Physical Examination of Foreign Manufactured Unapproved Prescription Drugs Distributed to Individuals in the U.S." verified
Country
CANADA verified
Address
10171 Yonge St , Richmond Hill, Ontario CANADA verified
Date published
09/10/2009 verified
Product code
65 P - - 02 Sildenafil Citrate (Regulator) | 66 B - - 99 Stimulant N.E.C. verified
Product
Sildenafil Citrate 50mg oral (sublingual route of administration) | Sildenafil Citrate 50mg oral (sublingual route of administration) verified
FDA notes
4/22/2003 | 4/22/2003 verified
Sourceaccessdata.fda.gov
Verified2026-08-06
Review by2026-10-05
DatasetFDA import alert red lists: firms subject to detention without physical examination

What the source says

Optimum Compounding Pharmacy Date Published : 09/10/2009 10171 Yonge St , Richmond Hill, Ontario CANADA 65 P - - 02 Sildenafil Citrate (Regulator) Date Published: 03/09/2021 Desc: Sildenafil Citrate 50mg oral (sublingual route of administration) Notes: 4/22/2003 66 B - - 99 Stimulant N.E.C. Date Published: 03/09/2021 Desc: Sildenafil Citrate 50mg oral (sublingual route of administration) Notes: 4/22/2003

accessdata.fda.gov, retrieved 2026-08-06

Source

Last verified against source: 2026-08-06. Due for re-check by 2026-10-05. This page as Markdown · OKF bundle · full dataset as JSON.